BackCOSCIENS Biopharma Overview

COSCIENS Biopharma Cost of Revenue

Cost of Revenue analysis for AEZS.

Quarterly Cost of Revenue

$1.52M
↑ 992.09% YoY

As of Jun 30, 2024

Annual Cost of Revenue (TTM)

$1.69M
↑ 664.45% YoY

Trailing 12 months ending Jun 30, 2024

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin